Climb Bio (CLYM) Retained Earnings (2021 - 2026)
Climb Bio (CLYM) posted Retained Earnings of $157000.0 for Q1 2026, up 100.05% on a QoQ basis from -$289.7 million in Q4 2025, and down 45.1% year-over-year from $286000.0 in Q1 2025.
Climb Bio (CLYM) Retained Earnings (2021 - 2026) Analysis & Trends
Climb Bio's Retained Earnings history runs 6 years deep, the most recent figure standing at $157000.0 for Q1 2026.
- Quarterly Retained Earnings fell 45.1% year-over-year to $157000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $157000.0 (down 45.1% YoY) and the FY2025 annual result came in at -$289.7 million, down 1259782.61% from the prior year.
- Retained Earnings was $157000.0 for Q1 2026 at Climb Bio, up from -$289.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at $469000.0 in Q3 2025 and bottomed at -$289.7 million in Q4 2025.
- A 5-year average of -$67.5 million and a median of -$358000.0 in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings tumbled 2013172.73% — and 2025, when it soared 100.21%.
- Climb Bio's Retained Earnings stood at -$358000.0 in 2022, then tumbled by 43469.55% to -$156.0 million in 2023, then surged by 100.01% to $23000.0 in 2024, then plunged by 1259782.61% to -$289.7 million in 2025, then soared by 100.05% to $157000.0 in 2026.
- Business Quant data shows CLYM's Retained Earnings at $157000.0 in Q1 2026, -$289.7 million in Q4 2025, and $469000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | 157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157,000.00 |
| Dec 31, 2025 | -289.73 Mn |
| Sep 30, 2025 | 469,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Mar 31, 2025 | 286,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | -221.46 Mn |
| Dec 31, 2023 | -155.98 Mn |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -35,000.00 |
| Mar 31, 2023 | -143.20 Mn |
| Dec 31, 2022 | -358,000.00 |
| Sep 30, 2022 | -113.10 Mn |
| Jun 30, 2022 | -604,000.00 |
| Mar 31, 2022 | -88.80 Mn |
| Dec 31, 2021 | -75.62 Mn |
| Sep 30, 2021 | -65.10 Mn |
| Jun 30, 2021 | -55.46 Mn |